15:02:28 RRSAgent has joined #hcls 15:02:28 logging to http://www.w3.org/2007/09/18-hcls-irc 15:02:51 Zakim, who's on the call? 15:03:02 On the phone I see Susie, Kerstin_Forsberg, Vipul_Kashyap 15:03:06 +[IBM] 15:03:55 +Rachel 15:05:04 rrsagent, make logs world-visible 15:07:13 +Alan 15:11:12 alanr has joined #hcls 15:11:25 starting with emr data 15:11:38 criteria given 15:11:59 output is list of patients with some/all criteria 15:15:20 ksrinivs@us.ibm.com 15:18:06 Trigger = start a full comparison of the criteria for all the protocols 15:20:22 Question: When are the criteria evaluated? 15:20:51 Possibilities: As patient is diagnosed, trial pops up as a possible one 15:21:07 or: A company comes asking for who are potential candidates 15:21:22 Helen has joined #hcls 15:22:07 kavintha: button on physician's console showing patient info asking if they want to see what trials are available 15:22:16 +Helen_Chen 15:22:44 -Vipul_Kashyap 15:22:47 Rachel: Who do we want the user to be 15:23:40 +Vipul_Kashyap 15:23:45 The patient's doctor? or the Study Recruiters? Rachel thinks we were leaning to the latter 15:24:12 We find pool of candidate 15:25:36 Susie: Protocol driven side is more compelling. 15:28:36 In the picture: Once the potential patients are identified, how are does the investigator make the final decision 15:30:57 +q 15:33:01 Helen's point: Some of the less easy to evaluate criteria can be evaluated by the physician at the site. 15:34:29 Helen: From the point of view of physician, this is considered value added. Physician and hospital gets money for identifying potential patients. 15:35:50 Action: Helen to send link to paper describing point system for evaluating patients 15:37:49 Action: Helen to send example of proof to the list 15:38:50 Vipul - issue with terminology. Differing definitions of diabetes according to MESH, SNOMED 15:39:33 helen - patient record says diabetes according to snomed 15:44:44 Issue for requirements. If criterion is in terms of SNOMED and record is in terms of MESH, then how is the criterion evaluated. 15:49:59 Action: Helen, Rachel to work on capturing Helen's "variation" of the use case. Combined evaluation/enrollment by doctor at site. 15:50:19 Action: Susie to ping people at Lilly to evaluate use case 15:50:50 Action: Bo and Kersten to ping people at Astra Zeneca to evaluate use case 15:51:33 Action: Vipul to contact people at Partners to evaluate. 15:51:37 Zakim, please dial ericP-office 15:51:37 ok, ericP; the call is being made 15:51:39 +EricP 15:53:10 discussion of tech plenary f2f meeting 15:53:20 what's on the agenda? 15:53:39 I wasn't asking you, Zakim, just noting what was being talked about 15:54:17 5th and 6th of november or the 8th or 9th of november 15:55:55 Action: Vipul to put up straw men agenda 15:56:37 Registration for the F2F - http://www.w3.org/2002/09/wbs/35125/TPAC2007/ 15:56:41 this is a complex feedback cycle 15:57:09 should converse within the next 6 months (given sufficient attention) 15:57:23 Goal of f2f - get more participation from relevant parties in pharma/ health care. 15:59:36 Discussion of who at Columbia can come to f2f, issue of whether they are willing to share (unlikely?) 16:02:33 IBM can use the patient data and share summary data, like counts, but not release of patient data without further permission 16:05:39 -Rachel 16:05:41 -Kerstin_Forsberg 16:05:43 -Vipul_Kashyap 16:05:44 -Helen_Chen 16:05:46 -[IBM] 16:05:49 -Susie 16:07:08 rrsagent, make minutes 16:07:08 I have made the request to generate http://www.w3.org/2007/09/18-hcls-minutes.html vipul 16:10:33 -EricP 16:10:34 SW_HCLS(Bio-Ont WG)11:00AM has ended 16:10:35 Attendees were Susie, Kerstin_Forsberg, Vipul_Kashyap, [IBM], Rachel, Alan, Helen_Chen, EricP 16:14:40 alanr has left #hcls 18:11:38 Zakim has left #hcls 19:28:15 RRSAgent, make log world-visible